Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
4
×
life sciences
national blog main
new york blog main
4
×
san diego blog main
san francisco blog main
san francisco top stories
biotech
boston blog main
national top stories
new york top stories
raleigh-durham blog main
san diego top stories
seattle blog main
seattle top stories
alnylam pharmaceuticals
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
fda
gene therapy
hemophilia
indiana blog main
indiana top stories
national
raleigh-durham top stories
rna
san francisco
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
adeno-associated virus
What
help
4
×
bio
deal
gene
long
roundup
therapy
treatment
acquisitions
adding
aims
announced
aren’t
ceo
collabs
company
covid
crude
cutting
daniel
decisions
despite
developers
diagnostic
diagnostics
drug
drugs
edge
effects
encoded
expand
fda
fold
gilead
gilead’s
illumina’s
imminent
introduce
ipo
lasting
Language
unset
Current search:
help
×
" new york blog main "
×
deals
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More